News | May 31, 2012

Occlutech Wins European Supreme Court Ruling on Cardiac Occluder Technology

May 31, 2012 Occlutech GmbH, a European developer of minimally invasive implants for the treatment of structural heart disease, announced receiving a favorable Supreme Court ruling from The Hague in The Netherlands in the ongoing patent litigation with AGA/St. Jude Medical. A first instance court ruling obtained in favour of Occlutech had been appealed by AGA in 2008, as had the favorable appeal court decision obtained in 2010.

In this final ruling, the Supreme Court saw no reason to change the favorable first instance and appeal court rulings. The Dutch Supreme court decision comes after Supreme Courts in Germany and the U.K. have decided in Occlutech's favour in the same matter and can't be appealed. Litigation in the same matter is ongoing in Italy, Sweden and Spain where Occlutech has won in the first instances.

"It is really sad to see the extent to which this large competitor is willing to go in order to try to keep a company with better technology off the market," said Tor Peters, Occlutech's CEO. "It is hard on Occlutech and our employees but the real losers are physicians and especially patients who have been denied superior products due to the aggressive litigation by AGA/St Jude Medical. We are dedicated not to give in to this kind of bullying and to continue to innovate, bringing superior products to the market."

Occlutech's own patent position has been continuously strengthened and a full pipeline of new technologies and products is being developed. Occlutech plans to launch additional occluder devices for indications such as PDA and VSD, in addition to second generation ASD and PFO occluders. In addition, an innovative LAA occluder, a new generation of stent grafts and cardiac valve intervention technology are also being developed.

For more information: www.occlutech.com

Related Content

FDA Approves Gore Cardioform Septal Occluder for PFO Closure Prevent Recurrent Ischemic Stroke
Technology | Structural Heart Occluders | April 03, 2018
April 3, 2018 — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen oval
Videos | Structural Heart Occluders | November 08, 2017
John Rhodes, M.D., co-director of the adult congenital heart program, Medical University of South Carolina, is the pr
Videos | Structural Heart Occluders | September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
University of Alabama at Birmingham, Amplatzer PFO Occluder, first implementation
News | Structural Heart Occluders | February 15, 2017
Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-...
Amplatzer PFO Occluder, St. Jude Medical, Baylor Heart and Vascular Services, Fort Worth, Texas, first patients
News | Structural Heart Occluders | February 01, 2017
Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to implant the Amplatzer...
RESPECT trial, Amplatzer PFO Occluder, St. Jude Medical, TCT 2016
News | Structural Heart Occluders | November 02, 2016
St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First Report session at the...
St. Jude Medical, Amplatzer PFO Occluder, FDA approval, U.S. launch
Technology | Structural Heart Occluders | November 02, 2016
St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval and launch of the...
PFO closure, patent foramen ovale, AAN recommendation, American Academy of Neurology, stroke patients
News | Structural Heart Occluders | August 08, 2016
Updated recommendations from the American Academy of Neurology (AAN) states that catheter-based closure should not be...
Videos | Structural Heart Occluders | June 16, 2016
This is an animation, supplied by Gore, demonstrated how the Cardioform Septal Occluder is implanted for the transcat
PFO occluder, amplatzer
Feature | Structural Heart Occluders | May 27, 2016 | Dave Fornell
May 27, 2016 — A U.S.
Overlay Init